{"url":"https://lda.senate.gov/api/v1/filings/ecb8f243-4383-41d1-baa5-e5f5d98a4a27/","filing_uuid":"ecb8f243-4383-41d1-baa5-e5f5d98a4a27","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ecb8f243-4383-41d1-baa5-e5f5d98a4a27/print/","filing_document_content_type":"text/html","income":"11250.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James W. Rock","dt_posted":"2019-01-17T13:10:54.127000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":33545,"url":"https://lda.senate.gov/api/v1/registrants/33545/","house_registrant_id":30422,"name":"ROCK & ASSOCIATES","description":"Government relations consultant.","address_1":"517 C Street, NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES W. ROCK","contact_telephone":"+1 703-627-8226","dt_updated":"2025-02-03T11:57:31.624210-05:00"},"client":{"id":141936,"url":"https://lda.senate.gov/api/v1/clients/141936/","client_id":125,"name":"WOMEN'S INTERNATIONAL PHARMACY","general_description":"Retail pharmacy.","client_government_entity":false,"client_self_select":false,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-04-16"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Patient Access to Compounded Medications Act of 2017.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":22837,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"W","last_name":"ROCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}